Revolution Medicines RVMD
NASDAQ RVMD
$199.86 +9.12 (+4.78%)
At close: Sep 24, 2026 · 4:00 PM EDT

Revolution Medicines (RVMD) Operating Margin (2019 - 2023)

Revolution Medicines (RVMD) posted Operating Margin of 24256.47% for Q4 2023, down 752.57% on a QoQ basis from 2845.11% in Q2 2023, and down 2385394.0% year-over-year from N/an in Q4 2022.

Analysis

Revolution Medicines (RVMD) Operating Margin (2019 - 2023) Analysis & Trends

Revolution Medicines has reported Operating Margin for 5 years, with the latest figure at 24256.47% in Q4 2023.

  • On a quarterly basis, Operating Margin fell 2385394.0% year-over-year to 24256.47% in Q4 2023; TTM through Sep 2024 was 88031.94%, a 8662217.0% decrease from a year earlier, with the FY2023 full-year figure at 4207.12%, down 347711.0% from the prior year.
  • Operating Margin was 24256.47% for Q4 2023 at Revolution Medicines, down from 2845.11% in the prior quarter.
  • The five-year high for Operating Margin was 79.26% in Q1 2019, with the low at 24256.47% in Q4 2023.
  • Average Operating Margin over 5 years is 2109.23%, with a median of 402.52% recorded in 2022.
  • The sharpest annual moves came in 2022 and 2023: Operating Margin jumped 254813 bps in 2022, then plunged 2385394 bps in 2023.
  • Over 5 years, Operating Margin stood at 161.85% in 2019, then plunged by 141 bps to 389.44% in 2020, then tumbled by 44 bps to 559.33% in 2021, then rose by 28 bps to 402.52% in 2022, then tumbled by 5926 bps to 24256.47% in 2023.
  • The last three Operating Margin figures came in at 24256.47% (Q4 2023), 2845.11% (Q2 2023), and 1071.53% (Q1 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 28.21%
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 37.86%
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn -3.52%
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn 32.97%
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn 20.57%
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 34.95%
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn -133.21%
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn 37.40%
10 Revolution Medicines 40.86 Bn 40.86 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -24,256.47%
Jun 30, 2023 -2,845.11%
Mar 31, 2023 -1,071.53%
Dec 31, 2022 -402.52%
Sep 30, 2022 -2,280.48%
Jun 30, 2022 -681.10%
Mar 31, 2022 -764.70%
Dec 31, 2021 -559.33%
Sep 30, 2021 -4,828.61%
Jun 30, 2021 -512.01%
Mar 31, 2021 -369.13%
Dec 31, 2020 -389.44%
Sep 30, 2020 -217.61%
Jun 30, 2020 -279.14%
Mar 31, 2020 -182.59%
Dec 31, 2019 -161.85%
Sep 30, 2019 -108.42%
Jun 30, 2019 -85.99%
Mar 31, 2019 -79.26%
API Access

Revolution Medicines Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=RVMD&period=max&api_key=YOUR_API_KEY